Episode of treatment for alcohol and other drugs—drug of concern (principal), (ASCDC 2011 extended) code NNNN
Identifying and definitional attributes
|Metadata item type:||Data Element|
|Short name:||Principal drug of concern|
|Registration status:||Health, Standard 07/12/2011|
ACT Health, Final 09/08/2018
|Definition:||The main drug, as stated by the client, that has led a person to seek treatment from the service, as represented by a code.|
|Context:||Required as an indicator of the client's treatment needs.|
|Data Element Concept:||Episode of treatment for alcohol and other drugs—drug of concern|
Value domain attributes
|Classification scheme:||Australian Standard Classification of Drugs of Concern 2011|
|Maximum character length:||4|
Collection and usage attributes
|Guide for use:|
The Australian Standard Classification of Drugs of Concern (ASCDC) provides a number of supplementary codes that have specific uses and these are detailed within the ASCDC, e.g. 0000 = inadequately described.
Other supplementary codes that are not already specified in the ASCDC may be used in National Minimum Data Sets (NMDS) when required. In the Alcohol and other drug treatment service NMDS, two additional supplementary codes have been created which enable a finer level of detail to be captured:
CODE 0005 Opioid analgesics not further defined
This code is to be used when it is known that the client's principal drug of concern is an opioid but the specific opioid used is not known. The existing code 1000 combines opioid analgesics and non-opioid analgesics together into Analgesics nfd and the finer level of detail, although known, is lost.
CODE 0006 Psychostimulants not further defined
This code is to be used when it is known that the client's principal drug of concern is a psychostimulant but not which type. The existing code 3000 combines stimulants and hallucinogens together into Stimulants and hallucinogens nfd and the finer level of detail, although known, is lost.
Psychostimulants refer to the types of drugs that would normally be coded to 3100-3199, 3300-3399 and 3400-3499 categories plus 3903 and 3905.
Data element attributes
Collection and usage attributes
|Guide for use:||The principal drug of concern should be the main drug of concern to the client and is the focus of the client's treatment episode. If the client has been referred into treatment and does not nominate a drug of concern, then the drug involved in the client's referral should be chosen.|
To be collected on commencement of the treatment episode.For clients whose treatment episode is related to the alcohol and other drug use of another person, this metadata item should not be collected.
Source and reference attributes
|Submitting organisation:||Intergovernmental Committee on Drugs National Minimum Data Set Working Group|
|Related metadata references:|
Supersedes Episode of treatment for alcohol and other drugs—drug of concern (principal), code (ASCDC 2000 extended) NNNN Health, Superseded 07/12/2011
|Implementation in Data Set Specifications:|
All attributes +
Alcohol and other drug treatment services NMDS 2012-13 Health, Superseded 07/02/2013
Alcohol and other drug treatment services NMDS 2013-15 Health, Superseded 13/11/2014
Alcohol and other drug treatment services NMDS 2015-18 Health, Superseded 06/09/2018
Alcohol and other drug treatment services NMDS 2018-19 Health, Superseded 12/12/2018
Alcohol and other drug treatment services NMDS 2019–20 Health, Standard 12/12/2018
Alcohol and other drug treatment services NMDS 2020–21 Health, Standard 20/02/2020